Access to investigational drugs in the USA.

Suppr

超能文献

出版信息

Lancet. 2007 Aug 18;370(9587):540. doi: 10.1016/S0140-6736(07)61266-5.

DOI:10.1016/S0140-6736(07)61266-5

PMID:17707730

Abstract

摘要

相似文献

Access to investigational drugs in the USA.

Lancet. 2007 Aug 18;370(9587):540. doi: 10.1016/S0140-6736(07)61266-5.

The terminally ill, access to investigational drugs, and FDA rules.

Virtual Mentor. 2013 Aug 1;15(8):687-91. doi: 10.1001/virtualmentor.2013.15.8.hlaw1-1308.

Individual patient treatment use of unapproved drugs: a new option for the seriously ill.

J Pain Palliat Care Pharmacother. 2010 Mar;24(1):19-22. doi: 10.3109/15360280903583057.

Cancer, access to investigational drugs, and patient rights in the U.S.A. and India.

Indian J Med Ethics. 2008 Oct-Dec;5(4):170-2; discussion 173. doi: 10.20529/IJME.2008.062.

Access for the terminally ill to experimental medical innovations: a three-pronged threat.

Am J Bioeth. 2007 Oct;7(10):3-6. doi: 10.1080/15265160701672255.

FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.

Food Drug Law J. 2009;64(1):183-223.

Right to try?

J Clin Oncol. 2015 May 1;33(13):1518. doi: 10.1200/JCO.2014.60.6004. Epub 2015 Mar 16.

Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.

J Law Med Ethics. 2009 Summer;37(2):269-79. doi: 10.1111/j.1748-720X.2009.00371.x.

False hope with the Right to Try Act.

Lancet. 2018 Jun 9;391(10137):2296. doi: 10.1016/S0140-6736(18)31266-2.

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Access to investigational drugs in the USA.

Lancet. 2007 Aug 18;370(9587):540. doi: 10.1016/S0140-6736(07)61266-5.

The terminally ill, access to investigational drugs, and FDA rules.

Virtual Mentor. 2013 Aug 1;15(8):687-91. doi: 10.1001/virtualmentor.2013.15.8.hlaw1-1308.

Individual patient treatment use of unapproved drugs: a new option for the seriously ill.

J Pain Palliat Care Pharmacother. 2010 Mar;24(1):19-22. doi: 10.3109/15360280903583057.

Cancer, access to investigational drugs, and patient rights in the U.S.A. and India.

Indian J Med Ethics. 2008 Oct-Dec;5(4):170-2; discussion 173. doi: 10.20529/IJME.2008.062.

Access for the terminally ill to experimental medical innovations: a three-pronged threat.

Am J Bioeth. 2007 Oct;7(10):3-6. doi: 10.1080/15265160701672255.

FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.

Food Drug Law J. 2009;64(1):183-223.

Right to try?

J Clin Oncol. 2015 May 1;33(13):1518. doi: 10.1200/JCO.2014.60.6004. Epub 2015 Mar 16.

Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.

J Law Med Ethics. 2009 Summer;37(2):269-79. doi: 10.1111/j.1748-720X.2009.00371.x.

False hope with the Right to Try Act.

Lancet. 2018 Jun 9;391(10137):2296. doi: 10.1016/S0140-6736(18)31266-2.

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.